Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:53:14.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study information regarding the efficacy and safety of a treatment for advanced melanoma, while adding a new version identifier and collaborators.
    Difference
    11%
    Check dated 2025-04-16T01:50:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 7, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.5%
    Check dated 2025-04-08T20:27:24.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T15:38:00.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T18:20:22.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page has updated the number of study locations from 37 to 41 and added specific locations in Georgia, Ohio, Germany, and Spain. Additionally, there are new dates related to the study's timeline.
    Difference
    5%
    Check dated 2025-02-10T09:18:30.000Z thumbnail image

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.